As the COVID-19 pandemic surpasses one year, its economic disruptions have been felt acutely by workers in cities around the world, though some locations have had remarkably different experiences. The effects of the economic downturn have been exacerbated by high costs of living in some metro areas, while other cities’ local economies (particularly those with high-tech industries) have demonstrated greater resilience and even started down the path of recovery.
The Milken Institute’s Best-Performing Cities Index, published annually since 1999, provides a tool for understanding how the future of work is shifting across different regional economies throughout the United States. This year’s version incorporated new measures of housing affordability and broadband access to account for economic inclusion.
How did these trends influence the rankings in 2021? What lessons can the best-performing US cities offer their counterparts? And how do US cities compare with other cities around the globe?
How are patient organizations taking on the challenge of diversity, equity, and inclusion within biomedical research to create better health outcomes for all patient populations, especially those historically excluded from research and...
Rajiv Ahuja, associate director at the Milken Institute, focusing on the future of aging, moderates this Advances in Science webinar with featured guest Richard J. Hodes, M.D., Director of the National Institute on Aging (NIA) at the...
How are nonprofit organizations leveraging venture philanthropy to accelerate the development of treatments and cures? As part of The Research Acceleration and Innovation Network (TRAIN) webinar series, FasterCures takes a deeper dive into...
One thing has been made abundantly clear during the COVID-19 pandemic. Californians are quitting their jobs at unprecedented rates. The recent job reports only continue to solidify this notion. Whether searching for better pay, more...
While employment in much of the United States has recovered successfully from the fallout of the COVID-19 pandemic, California remains one of the few states that has struggled to recoup jobs at a pace on par with the rest of the nation...
In a webinar on September 23, 2020, FasterCures brought together Peter Marks, director of the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research, Gwen Nichols, chief medical officer of the Leukemia &...
For too long, the need for national infrastructure solutions has been limited to conversations of roads, bridges and stalemates in Congress. The COVID-19 pandemic has altered the financial circumstances of many communities just as high...
Data from and about patients is essential to advance biomedical research and development, but its collection and dissemination can be a significant investment of time and resources for patient organizations that choose to be the...